Integer Holdings Corp

Integer Holdings Corp(ITGR)股票分析

$126.540

-0.025 (-0.02%)收盘时

Loading chart…
最高
126.660
开盘
126.560
成交量加权均价
126.58
成交量
603.13K
市值
3.84B
最低
126.530
成交额
76.34M
企业价值/息税折旧摊销前利润(TTM)
17.04

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.

AI 分析 of Integer Holdings Corp (ITGR)

持有

Integer Holdings Corp is currently not a strong buy due to its recent downgrades and market uncertainties. The stock is trading at $126.54, just below the acquisition price of $127, indicating limited upside potential. The RSI is at 37.997, suggesting it is nearing oversold territory, but the lack of a clear growth outlook and the withdrawal of guidance due to the acquisition creates uncertainty. The main risk is the projected sales growth slowing to 1.6% over the next 12 months, which could impact profitability.

分析师评级(5)

-31.84% 下跌空间
持有
2 买入
3 持有
0 卖出
当前: 126.54
最低
75.00
平均
86.25
最高
95.00

Benchmark

2026-08-13

目标价

—

持有

Piper Sandler

2026-08-03

目标价

$127

中性

KeyBanc

2026-08-03

目标价

$127

Sector Weight

BofA

2026-08-03

目标价

—

No Rating

Freedom Capital

2026-07-22

目标价

$112

买入

估值指标

Integer Holdings Corp(ITGR)当前预期市盈率为 22.42,5 年平均预期市盈率为 18.69。

预期市盈率

高估
5 年均值 P/E
18.69
当前P/E
22.42
高估
21.78
低估
15.61

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
12.85
当前EV/EBITDA
17.04
高估
14.53
低估
11.18

预期市销率

合理
5 年均值 P/S
1.90
当前P/S
2.23
高估
2.24
低估
1.56

Alphio AI 对 ITGR 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ITGR

$140.04

情景价格

基

基准

基准 · 50%ITGR

$133.90

情景价格

悲

悲观

悲观 · 25%ITGR

$130.08

情景价格

持有 ITGR 的大户

H

Heartland Advisors, Inc.

+ 持有ITGR

+1.90%

3个月收益率

N

Nomura Holdings, Inc.

+ 持有ITGR

-0.22%

3个月收益率

事件时间线

2026-09-30 (ET)

08:30:00

Integer Holdings Receives Early Termination of Antitrust Waiting Period

2026-08-04 (ET)

06:30:00

Freedom Capital Downgrades Integer to Hold, Price Target $127

2026-08-03 (ET)

17:00:00

Oppenheimer Downgrades Integer to Perform

17:00:00

U.S. Stocks Rise as Middle East Tensions Ease, Oil Prices Drop 5%

12:00:00

Amazon's Market Cap Surpasses $3 Trillion

资讯

ITGR 常见问题 —— 由 Alphio AI 解答

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Integer Holdings Corp is currently not a strong buy due to its recent downgrades and market uncertainties. The stock is trading at $126.54, just below the acquisition price of $127, indicating limited upside potential. The RSI is at 37.997, suggesting it is nearing oversold territory, but the lack of a clear growth outlook and the withdrawal of guidance due to the acquisition creates uncertainty. The main risk is the projected sales growth slowing to 1.6% over the next 12 months, which could impact profitability.

5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易